Filter News
Area of Research
- (-) Climate and Environmental Systems (1)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (1)
- Biology and Environment (42)
- Clean Energy (76)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (7)
- Electricity and Smart Grid (1)
- Fusion and Fission (3)
- Isotopes (3)
- Materials (22)
- Materials for Computing (6)
- National Security (15)
- Neutron Science (16)
- Quantum information Science (1)
- Sensors and Controls (2)
- Supercomputing (27)
- Transportation Systems (2)
News Type
News Topics
- (-) Biology (1)
- (-) Biomedical (2)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (6)
- Bioenergy (1)
- Climate Change (1)
- Computer Science (2)
- Decarbonization (1)
- Environment (4)
- Fusion (2)
- Isotopes (3)
- Materials Science (1)
- Mercury (1)
- Molten Salt (3)
- Neutron Science (3)
- Nuclear Energy (17)
- Physics (1)
- Space Exploration (4)
- Sustainable Energy (1)
- Transformational Challenge Reactor (1)
Media Contacts
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.